Immunome (IMNM) Cash from Investing Activities Growth (3y) (2022 - 2026)
Immunome (IMNM) Cash from Investing Activities Growth (3y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 46.78% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 66.14% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -39.73% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 296.32% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -53.57% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -246.81% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 27.84% |
| 10 | Immunome | 3.09 Bn | 2.57 Bn | - | -863.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -863.75% |
| Mar 31, 2026 | -383.97% |
| Dec 31, 2025 | -281.54% |
| Jun 30, 2025 | -622.71% |
| Mar 31, 2025 | 847.33% |
| Dec 31, 2024 | 787.48% |
| Sep 30, 2024 | 875.70% |
| Jun 30, 2024 | -2,069.48% |
| Mar 31, 2024 | -962.95% |
| Dec 31, 2023 | -767.22% |
| Sep 30, 2023 | 33.78% |
| Jun 30, 2023 | 1.98% |
| Mar 31, 2023 | -24.45% |
| Dec 31, 2022 | -2.43% |